Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
KYTHERA BIOPHARMACEUTICALS INC (KYTH)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-15 | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Selling, general and administrative | 41.5% | 28.3% | | | 43.3% | 36.6% | | |
| Research and development | 40.2% | 40.1% | 36.1% | 86.3% | 73.5% | 67.2% | 67.3% | |
| General and administrative | | | 13.3% | 24.3% | | | 31.9% | |
| Depreciation | 0.5% | 0.3% | 0.2% | 0.3% | 0.2% | 0.2% | 0.4% | |
| EBIT | -81.5% | -68.4% | -59.6% | -137.3% | -116.9% | -103.8% | -99.2% | |
| Pre-tax income | -84.9% | -71.7% | -102.4% | -248.5% | -226.8% | -212.4% | -102.8% | |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -84.9% | -71.7% | -102.4% | -248.5% | -226.8% | -212.4% | -102.8% | |
|